Staying Active With Ulcerative Colitis
Links shared publicly online about this topic
Gastroenterology Article | Colitis, Ulcerative
mdlinx.com — “Daily granulocyte and monocyte adsorptive apheresis in patients with active ulcerative colitis: a prospective safety and feasibility study” View full resource at mdlinx.com
Most Recently Shared on June 24, 2011 at 4:10 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Daily granulocyte and monocyte adsorptive apheresis in patients with active ulcerative colitis: a prospectiv... http://bit.ly/ly26vJ #GI
Colitis, Ulcerative on #MDlinx
mdlinx.com — “Colitis, Ulcerative on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 5, 2010 at 2:22 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Effects of an oral preparation of mesalazine at 4 g/day on moderately active ulcerative colitis. A phase III pa... http://bit.ly/cLUEjZ #GI
Gastroenterology Article | Ulcerative Colitis
mdlinx.com — “Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis- additional results from two controlled studies” View full resource at mdlinx.com
Most Recently Shared on August 19, 2011 at 12:41 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ul... http://t.co/Y4N6ciI #GI
Family Medicine Article | Colitis, Ulcerative
mdlinx.com — “Best practice in the management of mild-to-moderately active ulcerative colitis and achieving maintenance of remission using mesalazine” View full resource at mdlinx.com
Most Recently Shared on November 25, 2010 at 7:35 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Best practice in the management of mild-to-moderately active ulcerative colitis and achieving maint... http://bit.ly/hjPsrn #FamPractice
Ulcerative Colitis: eMedicine Gastroenterology
emedicine.medscape.com — “Overview: Ulcerative colitis (UC) is an idiopathic chronic inflammatory disorder limited to the colon (see the image below). Ulcerative colitis is a lifelong illness that has a profound emotional and social impact on patients who are affected.{{mediatitle:183178_1}}{{media:183178_1}}{{mediacaption:183178_1}} ...” View full resource at emedicine.medscape.com
Most Recently Shared on March 23, 2010 at 8:28 pm By:
Does infliximab therapy in moderately to severely active ulcerative colitis affect colectomy rates? http://bit.ly/bmO46F
Ulcerative Colitis - Questions for Your Doctor - What to Ask About Ulcerative Colitis - NY Times Health
health.nytimes.com — “Free articles and multimedia from the ny times, including information on symptoms, diagnosis, treatments, tests, and surgical procedures, as well as current news and interviews with leading experts. ” View full resource at health.nytimes.com
Most Recently Shared on January 14, 2010 at 6:33 pm By:
After a recent ulcerative colitis diagnosis, your head may be spinning. Here are questions to ask your physician. http://nyti.ms/50O4tt
Gastro Medical News about Colitis, Ulcerative
mdlinx.com — “Novel endoscopic activity index is useful for choosing treatment in severe active ulcerative colitis patients” View full resource at mdlinx.com
Most Recently Shared on April 20, 2010 at 3:04 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Novel endoscopic activity index is useful for choosing treatment in severe active ulcerative colitis patients: ... http://bit.ly/bAJnGY #GI
Phase 3 Study of Uceris for Ulcerative Colitis - MPR
empr.com — “Santarus, Inc. announced pooled data from two Phase 3 studies of Uceris (budesonide MMX) for the induction of remission of mild or moderate active ulcerative colitis.” View full resource at empr.com
Most Recently Shared on November 1, 2011 at 7:30 pm By:
Phase 3 Study of Uceris for Ulcerative #Colitis http://t.co/PLaOXrl5
Why a Food Diary Can Help - Ulcerative Colitis - Health.com
health.com — “Why a Food Diary Can Help - Ulcerative Colitis - Health.com” View full resource at health.com
Most Recently Shared on April 21, 2010 at 8:47 pm By:
Why a food diary can help with ulcerative colitis http://bit.ly/cnuVl2
Allergy/Imm Medical News about Colitis, Ulcerative
mdlinx.com — “Activation of signal transducer and activator of transcription-1 (STAT-1) and differential expression of interferon-gamma and anti-inflammatory proteins in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis” View full resource at mdlinx.com
Most Recently Shared on May 15, 2010 at 1:26 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Activation of signal transducer and activator of transcription-1 (STAT-1) and differential expression o... http://bit.ly/dcg7mx #AI #mdlinx
Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients - ONA
oncologynurseadvisor.com — “Centocor Ortho Biotech announced results from its Phase 3 study of Remicade (infliximab) in the treatment of pediatric patients with moderately to severely active ulcerative colitis (UC).” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 10, 2011 at 3:36 pm By:
OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education
Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients http://goo.gl/fb/qYVQj
FDA approves Remicade to treat ulcerative colitis in children - News
virtualmedicalcentre.com — “The U.S. Food and Drug Administration today approved Remicade (infliximab) to treat moderately to severely active ulcerative colitis (UC) in children 6 years and older who have had inadequate response to conventional therapy.” View full resource at virtualmedicalcentre.com
Most Recently Shared on October 9, 2011 at 2:07 pm By:
VirtualMedicalCentre Health Site
FDA approves Remicade to treat ulcerative colitis in children http://t.co/oERwrjn9 #Healthnews
Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients - MPR
empr.com — “Centocor Ortho Biotech announced results from its Phase 3 study of Remicade (infliximab) in the treatment of pediatric patients with moderately to severely active ulcerative colitis (UC).” View full resource at empr.com
Most Recently Shared on May 10, 2011 at 3:54 pm By:
MPR News: Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients: Centocor Ortho Biotech announc... http://bit.ly/mK0h6c
Altheus Therapeutics announces completion of Zoenasa phase I trial for ulcerative colitis
news-medical.net — “Altheus Therapeutics, announced that it has completed a two dose, double-blind, active-controlled Phase I clinical trial of the safety and tolerability of Zoenasa Rectal Suspension in adult patients with left-sided, or distal, ulcerative colitis.” View full resource at news-medical.net
Most Recently Shared on January 7, 2011 at 4:57 am By:
Altheus Therapeutics announces completion of Zoenasa phase I trial for ulcerative colitis: Altheus Therapeutics,... http://bit.ly/gAqdLS
Supplemental BLA submitted for Remicade for pediatric ulcerative colitis - MPR
empr.com — “Centocor Ortho Biotech announced that it submitted a supplemental Biologics License Application (sBLA) to the FDA for Remicade (infliximab) for the treatment of moderately to severely active ulcerative colitis (UC) in pediatric patients who have had an inadequate response to conventional therapy.” View full resource at empr.com
Most Recently Shared on December 29, 2010 at 4:14 pm By:
MPR News: Supplemental BLA submitted for Remicade for pediatric ulcerative colitis: Centocor Ortho Biotech annou... http://bit.ly/erEMRU
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
